Sign in

CIK 0001689375

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

Entrada Therapeutics, Inc.

Sign in to watch
Ticker
TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813983399
Phone
+1 857-305-1825
Business address
ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
Former names
CycloPorters, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,200,939
in 8 filings

Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 21 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-08-18 WENTWORTH KORY JAMES Chief Financial Officer Option exercise +100 $2.10 $210 20,441
2022-08-18 WENTWORTH KORY JAMES Chief Financial Officer Sale −200 $13.00 $3K 20,221
2022-08-18 WENTWORTH KORY JAMES Chief Financial Officer Option exercise · Stock Option (Right to Buy) −100 115,896
2022-08-17 WENTWORTH KORY JAMES Chief Financial Officer Option exercise +100 $2.10 $210 20,541
2022-08-17 WENTWORTH KORY JAMES Chief Financial Officer Sale −200 $13.07 $3K 20,341
2022-08-17 WENTWORTH KORY JAMES Chief Financial Officer Option exercise · Stock Option (Right to Buy) −100 115,996
2022-08-16 WENTWORTH KORY JAMES Chief Financial Officer Option exercise +100 $2.10 $210 20,641
2022-08-16 WENTWORTH KORY JAMES Chief Financial Officer Sale −200 $13.00 $3K 20,441
2022-08-16 WENTWORTH KORY JAMES Chief Financial Officer Option exercise · Stock Option (Right to Buy) −100 116,096
2022-07-27 Doshi Dipal President and CEO Sale −2,000 $12.00 $24K 208,710
2022-07-01 WENTWORTH KORY JAMES Chief Financial Officer Grant or award · Stock Option (Right to Buy) +33,019 33,019
2022-07-01 KREHER NERISSA Chief Medical Officer Grant or award · Stock Option (Right to Buy) +31,032 31,032
2022-07-01 Dowden Nathan J Chief Operating Officer Grant or award · Stock Option (Right to Buy) +33,788 33,788
2022-07-01 Sethuraman Natarajan Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +34,763 34,763
2022-07-01 Doshi Dipal President and CEO Grant or award · Stock Option (Right to Buy) +90,750 90,750
2022-06-27 Dowden Nathan J Chief Operating Officer Sale −7,714 $13.00 $100K 64,893
2022-06-27 Doshi Dipal President and CEO Sale −4,000 $12.00 $48K 210,710
2022-06-06 BAKER BROS. ADVISORS LP 10% owner Purchase +921 $6.35 $6K 361,043
2022-06-06 BAKER BROS. ADVISORS LP 10% owner Purchase +7,815 $6.35 $50K 4,475,208
2022-06-06 BAKER BROS. ADVISORS LP 10% owner Purchase +3,118 $6.42 $20K 364,161

Page 24 of 26 · 517 trades